Literature DB >> 30794995

Fiducial marker based intra-fraction motion assessment on cine-MR for MR-linac treatment of prostate cancer.

D M de Muinck Keizer1, A U Pathmanathan, A Andreychenko, L G W Kerkmeijer, J R N van der Voort van Zyp, A C Tree, C A T van den Berg, J C J de Boer.   

Abstract

We have developed a method to determine intrafraction motion of the prostate through automatic fiducial marker (FM) tracking on 3D cine-magnetic resonance (MR) images with high spatial and temporal resolution. Twenty-nine patients undergoing prostate stereotactic body radiotherapy (SBRT), with four implanted cylindrical gold FMs, had cine-MR imaging sessions after each of five weekly fractions. Each cine-MR examination consisted of 55 sequentially obtained 3D datasets ('dynamics'), acquired over a 11 s period, covering a total of 10 min. FM locations in the first dynamic were manually identified by a clinician, FM centers in subsequent dynamics were automatically determined. Center of mass (COM) translations and rotations were determined by calculating the rigid transformations between the FM template of the first and subsequent dynamics. The algorithm was applied to 7315 dynamics over 133 scans of 29 patients and the obtained results were validated by comparing the COM locations recorded by the clinician at the halfway-dynamic (after 5 min) and end dynamic (after 10 min). The mean COM translations at 10 min were X: 0.0 [Formula: see text] 0.8 mm, Y: 1.0 [Formula: see text] 1.9 mm and Z: 0.9 [Formula: see text] 2.0 mm. The mean rotation results at 10 min were X: 0.1 [Formula: see text] 3.9°, Y: 0.0 [Formula: see text] 1.3° and Z: 0.1 [Formula: see text] 1.2°. The tracking success rate was 97.7% with a mean 3D COM error of 1.1 mm. We have developed a robust, fast and accurate FM tracking algorithm for cine-MR data, which allows for continuous monitoring of prostate motion during MR-guided radiotherapy (MRgRT). These results will be used to validate automatic prostate tracking based on soft-tissue contrast.

Entities:  

Mesh:

Year:  2019        PMID: 30794995     DOI: 10.1088/1361-6560/ab09a6

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  14 in total

1.  Dosimetric Impact of the Positional Imaging Frequency for Hypofractionated Prostate Radiotherapy - A Voxel-by-Voxel Analysis.

Authors:  Mona Splinter; Ilias Sachpazidis; Tilman Bostel; Tobias Fechter; Constantinos Zamboglou; Christian Thieke; Oliver Jäkel; Peter E Huber; Jürgen Debus; Dimos Baltas; Nils H Nicolay
Journal:  Front Oncol       Date:  2020-09-29       Impact factor: 6.244

2.  Dosimetric Impact of Interfractional Variations in Prostate Cancer Radiotherapy-Implications for Imaging Frequency and Treatment Adaptation.

Authors:  Tilman Bostel; Ilias Sachpazidis; Mona Splinter; Nina Bougatf; Tobias Fechter; Constantinos Zamboglou; Oliver Jäkel; Peter E Huber; Dimos Baltas; Jürgen Debus; Nils H Nicolay
Journal:  Front Oncol       Date:  2019-09-27       Impact factor: 6.244

Review 3.  MR-Guided Radiotherapy for Prostate Cancer.

Authors:  Boris R Tocco; Amar U Kishan; Ting Martin Ma; Linda G W Kerkmeijer; Alison C Tree
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

4.  Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study.

Authors:  Thomas Willigenburg; Ellis Beld; Jochem Hes; Jan J W Lagendijk; Hans C J de Boer; Marinus A Moerland; Jochem R N van der Voort van Zyp
Journal:  Phys Imaging Radiat Oncol       Date:  2020-08-07

5.  External beam radiotherapy for prostate cancer: What are the current research trends and hotspots?

Authors:  Rui Li; Xia Liu; Bo Yang; Jie Qiu
Journal:  Cancer Med       Date:  2021-01-21       Impact factor: 4.452

6.  Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator.

Authors:  Mariska D den Hartogh; Hans C J de Boer; Eline N de Groot-van Breugel; Jochem R N van der Voort van Zyp; Jochem Hes; Uulke A van der Heide; Floris Pos; Karin Haustermans; Tom Depuydt; Robert Jan Smeenk; Martina Kunze-Busch; Bas W Raaymakers; Linda G W Kerkmeijer
Journal:  Phys Imaging Radiat Oncol       Date:  2019-07-15

7.  On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy.

Authors:  Daan M de Muinck Keizer; Jochem R N van der Voort van Zyp; Eline N de Groot-van Breugel; Bas W Raaymakers; Jan J W Lagendijk; Hans C J de Boer
Journal:  Phys Imaging Radiat Oncol       Date:  2021-07-25

8.  Automatic 3D Monte-Carlo-based secondary dose calculation for online verification of 1.5 T magnetic resonance imaging guided radiotherapy.

Authors:  Marcel Nachbar; David Mönnich; Oliver Dohm; Melissa Friedlein; Daniel Zips; Daniela Thorwarth
Journal:  Phys Imaging Radiat Oncol       Date:  2021-06-21

9.  Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.

Authors:  Annika Mannerberg; Emilia Persson; Joakim Jonsson; Christian Jamtheim Gustafsson; Adalsteinn Gunnlaugsson; Lars E Olsson; Sofie Ceberg
Journal:  Radiat Oncol       Date:  2020-07-10       Impact factor: 3.481

10.  Dosimetric Impact of Interfractional Variations for Post-prostatectomy Radiotherapy to the Prostatic Fossa-Relevance for the Frequency of Position Verification Imaging and Treatment Adaptation.

Authors:  Mona Splinter; Tilman Bostel; Ilias Sachpazidis; Tobias Fechter; Constantinos Zamboglou; Oliver Jäkel; Peter E Huber; Jürgen Debus; Dimos Baltas; Nils H Nicolay
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.